Successful Cell Therapy Roadtrip in Japan !
TreeFrog Therapeutics was Japan from the 10th to 21th of September 2019 to meet key academic and industry players. Notably, our team gave a presentation at the mecca of iPS : the Center for iPS Cell Research and Application (CiRA), Kyoto University. And on September 18th, Maxime Feyeux,...
20 September, 2019
Press release : TreeFrog Therapeutics receives additional €3M non-dilutive funding
TreeFrog Therapeutics receives additional €3M non-dilutive funding to mass-produce clinical-grade cell therapies by 2021 Company awarded close to €3M ($3.3M) in public grants only five months after Series A round of €7M ($7.8M) Bordeaux, France, September 5, 2019 – TreeFrog Therapeutics, an expert stem cell company, today announces...
05 September, 2019
Cell therapy roadtrip in Japan
TreeFrog will be in Japan from the 10th to 21th of September 2019 to meet key academic and industry players ! This cell therapy roadtrip, organized with the help of Business France, will be marked by our participation to Cell Therapy Word Asia 2019 on Sept 18-19 !...
03 September, 2019
TreeFrog’s CEO/CTO cited in Labiotech.eu
Kevin Alessandri, CEO/CTO of TreeFrog was cited in a recent article of Labiotech.eu on the current obstacles preventing cell therapies to become mainstream. Read more...
29 May, 2019
Labiotech.eu : Cell Encapsulation Biotech Raises €7M to Target Cell Therapy Bottlenecks
Read the article here...
13 May, 2019
TreeFrog Therapeutics raises over €7M ($7.8M)
TreeFrog Therapeutics raises over €7M ($7.8M) in Series A financing round 6 months after incorporationFunding to scale-up company’s proprietary technology C-Stem™ for mass-production of safe and affordable cell therapiesBordeaux, France, May 13, 2019 – TreeFrog Therapeutics, an expert stem cell company, today announces that it has...
13 May, 2019
Meet us in London on May 16-17
We will be at booth P8 ! Let’s discuss cell therapy mass production there !Learn about the event...
07 May, 2019
Press release : TreeFrog Therapeutics delivers first batch of Stem Cells (hIPS), with best in class quality check, to cell and gene therapy leader Imagine Institute
C- Stem™ technology introduces a new standard for hIPS suspension culture. Based on biomimetic stem cell culture in 3D, C- Stem™ enables cell therapy production scale-up while ensuring genomic and phenotypic stability Bordeaux, France, April 16, 2019 – TreeFrog Therapeutics, an expert stem cell company, today announces that...
15 April, 2019